sur AIAI Holdings (NASDAQ:AIAI)
MediGuide Launches Longevity Intelligence for Preventive Healthcare
AIAI Holdings Corporation has introduced the Longevity Intelligence Service through its portfolio company, MediGuide. This innovative service blends advanced diagnostics, predictive health intelligence, and physician expertise to offer personalized preventive healthcare solutions. The focus is on early detection and personalized clinical guidance.
Todd Furniss, CEO of AIAI Holdings, emphasized the strategic expansion as a move from Medical Second Opinions to precision healthcare, enhancing MediGuide's market position. CEO Vera Guerreiro of MediGuide highlighted the service's role in helping individuals understand their health proactively, combining biomarker evaluation, lifestyle analysis, and personalized recommendations.
MediGuide's approach involves four integrated layers: Biological Intelligence, Trajectory Intelligence, Intervention Intelligence, and Delivery Intelligence, aimed at providing comprehensive health insights and care pathway recommendations.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AIAI Holdings